Risperidone in the treatment of schizophrenia.: A therapy study.

被引：0
|
作者：
Stuppäck, CH [1 ]
机构：
[1] Landesnervenklin Salzburg, Psychiat Abt 1, A-5020 Salzburg, Austria
来源：
NEUROPSYCHIATRIE | 1999年 / 13卷 / 01期
关键词：
risperidone; schizophrenia; therapy study;
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
260 in- and outpatients suffering from schizophrenia were included in a therapy study with Risperidone. The mean daily dose amounted to 3.9 mg. The mean treatment periode was 104 days (s.d. +/- 61). Patients showed a statistically significant decrease in the rating scales used (CGI, BPRS, PANSS). Risperidone was very well tolerated, only 4.2% of the patients had to be withdrawn due to side effects. Another important result of the study presented is, that extrapyramidal motoric symptoms decreased significantly during the treatment with Risperidone. Rispsridone proved to be effective in schizophrenic patients against positive as well as negative symptoms and showed a favourable side effect profile.
引用
收藏
页码：18 / 22
页数：5
相关论文
共 50 条
  • [1] Antipsychotic monotherapy with olanzapine, risperidone, and quetiapine in the treatment of schizophrenia.
    Faries, D
    Zhu, BJ
    Jiang, Q
    Ascher-Svanum, H
    PHARMACOTHERAPY, 2003, 23 (10): : 1359 - 1360
  • [2] Pharmacokinetics (PK) of donepezil and risperidone in males with schizophrenia.
    Reyes, JF
    Preskorn, S
    Khan, A
    Kumar, D
    Cullen, E
    Pratt, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P44 - P44
  • [3] Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO study)
    Garcia-Cabeza
    Gomez, JC
    Sacristan, JA
    Edgell, E
    de Chavez, MG
    Gavart, S
    EUROPEAN PSYCHIATRY, 2000, 15 : 407S - 407S
  • [4] Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study)
    Garcia-Cabeza, Ignacio
    Gomez, Juan-Carlos
    Sacristan, Jose A.
    Edgell, Eric
    Gonzalez de Chavez, Manuel
    BMC PSYCHIATRY, 2001, 1 (1)
  • [5] Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study)
    Ignacio García-Cabeza
    Juan-Carlos Gómez
    Jose A Sacristán
    Eric Edgell
    Manuel González de Chavez
    BMC Psychiatry, 1
  • [6] Choice of and decreasing of the dosage of risperidone in the treatment of schizophrenia.: Global versus individual criteria
    Gomez-Perretta, C.
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2007, 35 (01): : 77 - 78
  • [7] GENETIC OVERLAP BETWEEN MEMORY AND SCHIZOPHRENIA. THE MAUDSLEY TWIN STUDY.
    Rodger, Annelise Kristin
    Owens, S. F.
    Rijsdijk, F. V.
    Picchioni, M. M.
    Waters-Metenier, S.
    Murray, R. M.
    Toulopoulou, T.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 118 - 118
  • [8] On the fever therapy of schizophrenia.
    Drecker, G
    ARCHIV FUR PSYCHIATRIE UND NERVENKRANKHEITEN, 1930, 89 : 39 - 56
  • [9] Cognitive therapy of schizophrenia.
    Pomini, Valentino
    SWISS JOURNAL OF PSYCHOLOGY, 2006, 65 (02): : 137 - 137
  • [10] CONVULSION THERAPY IN SCHIZOPHRENIA.
    Kennedy, Alexander
    JOURNAL OF MENTAL SCIENCE, 1937, 83 (347): : 609 - 629
12345